MYMeicheng Yang

Meicheng Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Meicheng Yang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enhancing Patient Selection in Sepsis Clinical Trials Design Through an AI Enrichment Strategy: Algorithm Development and Validation

    by Meicheng Yang, Jinqiang Zhuang, Wenhan Hu, Jianqing Li, Yu Wang, Zhongheng Zhang, Chengyu Liu, Hui Chen

    Background: Sepsis is a heterogeneous syndrome, and enrollment of more homogeneous patients is essential to improve the efficiency of clinical trials. Artificial intelligence (AI) has facilitated the identification of homogeneous subgroups, but how to estimate the uncertainty of the model outputs when applying AI to clinical decision-making remains unknown. Objective: We aimed to design an AI-based model for purposeful patient enrollment, ensuring that a patient with sepsis recruited into a trial would still be persistently ill by the time the proposed therapy could impact patient outcome. We also expected that the model could provide interpretable factors and estimate the uncertainty of the model outputs at a customized confidence level. Methods: In this retrospective study, 9135 patients with sepsis requiring vasopressor treatment within 24 hours after sepsis onset were enrolled from Beth Israel Deaconess Medical Center. This cohort was used for model development, and 10-fold cross-validation with 50 repeats was used for internal validation. In total, 3743 patients with sepsis from the eICU Collaborative Research Database were used as the external validation cohort. All included patients with sepsis were stratified based on disease progression trajectories: rapid death, recovery, and persistent ill. A total of 148 variables were selected for predicting the 3 trajectories. Four machine learning algorithms with 3 different setups were used. We estimated the uncertainty of the model outputs using conformal prediction (CP). The Shapley Additive Explanations method was used to explain the model. Results: The multiclass gradient boosting machine was identified as the best-performing model with good discrimination and calibration performance in both validation cohorts. The mean area under the receiver operating characteristic curve with SD was 0.906 (0.018) for rapid death, 0.843 (0.008) for recovery, and 0.807 (0.010) for persistent ill in the internal validation cohort. In the external validation cohort, the mean area under the receiver operating characteristic curve (SD) was 0.878 (0.003) for rapid death, 0.764 (0.008) for recovery, and 0.696 (0.007) for persistent ill. The maximum norepinephrine equivalence, total urine output, Acute Physiology Score III, mean systolic blood pressure, and the coefficient of variation of oxygen saturation contributed the most. Compared to the model without CP, using the model with CP at a mixed confidence approach reduced overall prediction errors by 27.6% (n=62) and 30.7% (n=412) in the internal and external validation cohorts, respectively, as well as enabled the identification of more potentially persistent ill patients. Conclusions: The implementation of our model has the potential to reduce heterogeneity and enroll more homogeneous patients in sepsis clinical trials. The use of CP for estimating the uncertainty of the model outputs allows for a more comprehensive understanding of the model’s reliability and assists in making informed decisions based on the predicted outcomes.


  • Open Access

    Development and Validation of an Interpretable Conformal Predictor to Predict Sepsis Mortality Risk: Retrospective Cohort Study

    by Meicheng Yang, Hui Chen, Wenhan Hu, Massimo Mischi, Caifeng Shan, Jianqing Li, Xi Long, Chengyu Liu

    Background: Early and reliable identification of patients with sepsis who are at high risk of mortality is important to improve clinical outcomes. However, 3 major barriers to artificial intelligence (AI) models, including the lack of interpretability, the difficulty in generalizability, and the risk of automation bias, hinder the widespread adoption of AI models for use in clinical practice. Objective: This study aimed to develop and validate (internally and externally) a conformal predictor of sepsis mortality risk in patients who are critically ill, leveraging AI-assisted prediction modeling. The proposed approach enables explaining the model output and assessing its confidence level. Methods: We retrospectively extracted data on adult patients with sepsis from a database collected in a teaching hospital at Beth Israel Deaconess Medical Center for model training and internal validation. A large multicenter critical care database from the Philips eICU Research Institute was used for external validation. A total of 103 clinical features were extracted from the first day after admission. We developed an AI model using gradient-boosting machines to predict the mortality risk of sepsis and used Mondrian conformal prediction to estimate the prediction uncertainty. The Shapley additive explanation method was used to explain the model. Results: A total of 16,746 (80%) patients from Beth Israel Deaconess Medical Center were used to train the model. When tested on the internal validation population of 4187 (20%) patients, the model achieved an area under the receiver operating characteristic curve of 0.858 (95% CI 0.845-0.871), which was reduced to 0.800 (95% CI 0.789-0.811) when externally validated on 10,362 patients from the Philips eICU database. At a specified confidence level of 90% for the internal validation cohort the percentage of error predictions (n=438) out of all predictions (n=4187) was 10.5%, with 1229 (29.4%) predictions requiring clinician review. In contrast, the AI model without conformal prediction made 1449 (34.6%) errors. When externally validated, more predictions (n=4004, 38.6%) were flagged for clinician review due to interdatabase heterogeneity. Nevertheless, the model still produced significantly lower error rates compared to the point predictions by AI (n=1221, 11.8% vs n=4540, 43.8%). The most important predictors identified in this predictive model were Acute Physiology Score III, age, urine output, vasopressors, and pulmonary infection. Clinically relevant risk factors contributing to a single patient were also examined to show how the risk arose. Conclusions: By combining model explanation and conformal prediction, AI-based systems can be better translated into medical practice for clinical decision-making.


  • An Atrial Fibrillation Detection Strategy in Dynamic ECGs With Significant Individual Differences

    by Caiyun Ma, Xi Long, Weijie Sheng, Rik Vullings, Meicheng Yang, Lina Zhao, Ronald M. Aarts, Jianqing Li, Chengyu Liu

    Atrial fibrillation (AF) is an insidious disease. Many long-term wearable electrocardiogram (ECG) monitoring devices have been used to monitor AF. The accuracy of detectors used to classify AF/sinus rhythm is already very high on the public database. Due to the significant individual differences and interference from other arrhythmias (e.g., premature beats), the performance of the developed AF detectors can degrade when tested on wearable ECGs. To tackle this, we proposed to use domain-adversarial (DA) learning strategy to minimize feature distribution between the annotated public ECG database (the MIT-BIH AF database) and unlabeled dynamic ECG recordings to improve AF recognition accuracy. DA algorithms based on the shifted window Transformer (DA-ST) and residual neural network (DA-RN) were proposed and validated on the 2021 China Physiological Signal Challenge (CPSC) database including four datasets. The accuracies were 93.85%, 89.78%, 91.93%, and 87.35% on the four datasets when using DA-ST. The corresponding results were 96.67%, 92.25%, 90.58%, and 89.46% when utilizing DA-RN. Importantly, these results demonstrated superior performance compared to the results obtained without DA. The proposed method was validated on 12 wearable long-term recordings, consisting of 4 recordings with premature beats, 4 recordings of AF with premature beats, 2 recordings of sinus rhythms, and 2 recordings of AF. The average results were 98.67% (DA-ST) and 97.89% (DA-RN), proving that the proposed method could provide reliable AF detection for dynamic ECG recordings with significant individual differences.


  • Open Access

    Enhancing Patient Selection in Sepsis Clinical Trials Design Through an AI Enrichment Strategy: Algorithm Development and Validation (Preprint)

    by Meicheng Yang, Jinqiang Zhuang, Wenhan Hu, Jianqing Li, Yu Wang, Zhongheng Zhang, Chengyu Liu, Hui Chen

    BACKGROUND Sepsis is a heterogeneous syndrome, and enrollment of more homogeneous patients is essential to improve the efficiency of clinical trials. Artificial intelligence (AI) has facilitated the identification of homogeneous subgroups, but how to estimate the uncertainty of the model outputs when applying AI to clinical decision-making remains unknown. OBJECTIVE We aimed to design an AI-based model for purposeful patient enrollment, ensuring that a patient with sepsis recruited into a trial would still be persistently ill by the time the proposed therapy could impact patient outcome. We also expected that the model could provide interpretable factors and estimate the uncertainty of the model outputs at a customized confidence level. METHODS In this retrospective study, 9135 patients with sepsis requiring vasopressor treatment within 24 hours after sepsis onset were enrolled from Beth Israel Deaconess Medical Center. This cohort was used for model development, and 10-fold cross-validation with 50 repeats was used for internal validation. In total, 3743 patients with sepsis from the eICU Collaborative Research Database were used as the external validation cohort. All included patients with sepsis were stratified based on disease progression trajectories: rapid death, recovery, and persistent ill. A total of 148 variables were selected for predicting the 3 trajectories. Four machine learning algorithms with 3 different setups were used. We estimated the uncertainty of the model outputs using conformal prediction (CP). The Shapley Additive Explanations method was used to explain the model. RESULTS The multiclass gradient boosting machine was identified as the best-performing model with good discrimination and calibration performance in both validation cohorts. The mean area under the receiver operating characteristic curve with SD was 0.906 (0.018) for rapid death, 0.843 (0.008) for recovery, and 0.807 (0.010) for persistent ill in the internal validation cohort. In the external validation cohort, the mean area under the receiver operating characteristic curve (SD) was 0.878 (0.003) for rapid death, 0.764 (0.008) for recovery, and 0.696 (0.007) for persistent ill. The maximum norepinephrine equivalence, total urine output, Acute Physiology Score III, mean systolic blood pressure, and the coefficient of variation of oxygen saturation contributed the most. Compared to the model without CP, using the model with CP at a mixed confidence approach reduced overall prediction errors by 27.6% (n=62) and 30.7% (n=412) in the internal and external validation cohorts, respectively, as well as enabled the identification of more potentially persistent ill patients. CONCLUSIONS The implementation of our model has the potential to reduce heterogeneity and enroll more homogeneous patients in sepsis clinical trials. The use of CP for estimating the uncertainty of the model outputs allows for a more comprehensive understanding of the model’s reliability and assists in making informed decisions based on the predicted outcomes.

  • Open Access

    Identification of indications for albumin administration in septic patients with liver cirrhosis

    by Wenhan Hu, Hui Chen, Chencheng Ma, Qin Sun, Meicheng Yang, Haofei Wang, Qingyun Peng, Jinlong Wang, Chen Zhang, Wei Huang, et al.

    Background: Albumin infusion is the primary therapeutic strategy for septic patients with liver cirrhosis. Although recent studies have investigated the efficacy of albumin in the resuscitation stage of septic patients with liver cirrhosis, it remains unclear whether daily albumin administration can improve outcomes. Furthermore, the indications for initiating albumin therapy are not well defined. Methods: Septic patients with liver cirrhosis were obtained from the Medical Information Mart for Intensive Care (MIMIC-IV 2.0) database. Marginal structural Cox models were employed to investigate the association between daily albumin infusion and 28-day mortality. We also aimed to explore under what circumstances enrolled patients could benefit most from albumin administration, based on the clinical parameters collected on the day of albumin infusion, including serum albumin concentration, serum lactate concentration, mean arterial pressure (MAP), and vasopressor dosage. Results: A total of 2265 patients were included in the final analysis, of whom 1093 (48.3%) had received albumin treatment at least once. The overall 28-day mortality was 29.6%. After marginal structural modeling, daily albumin infusion was associated with a reduced risk of 28-day death (hazard ratio, 0.76; 95% CI 0.61–0.94). We found that patients benefit most from albumin infusion when initiated on the day of serum albumin concentration between 2.5 and 3.0 g/dL, serum lactate concentration greater than or equal to 2 mmol/L, MAP less than 60 mmHg, or vasopressor dosage between 0.2 and 0.3 mcg/kg/min (norepinephrine equivalent, NEE). Conclusions: Albumin infusion is associated with a reduction in mortality in septic patients with liver cirrhosis under specific circumstances. Serum albumin concentration, serum lactate, MAP, and vasopressor dosage were found to be modifiers of treatment effectiveness and should be considered when deciding to initial albumin infusion.


  • Open Access

    Development and Validation of an Interpretable Conformal Predictor to Predict Sepsis Mortality Risk: Retrospective Cohort Study (Preprint)

    by Meicheng Yang, Hui Chen, Wenhan Hu, Massimo Mischi, Caifeng Shan, Jianqing Li, Xi Long, Chengyu Liu

    BACKGROUND Early and reliable identification of patients with sepsis who are at high risk of mortality is important to improve clinical outcomes. However, 3 major barriers to artificial intelligence (AI) models, including the lack of interpretability, the difficulty in generalizability, and the risk of automation bias, hinder the widespread adoption of AI models for use in clinical practice. OBJECTIVE This study aimed to develop and validate (internally and externally) a conformal predictor of sepsis mortality risk in patients who are critically ill, leveraging AI-assisted prediction modeling. The proposed approach enables explaining the model output and assessing its confidence level. METHODS We retrospectively extracted data on adult patients with sepsis from a database collected in a teaching hospital at Beth Israel Deaconess Medical Center for model training and internal validation. A large multicenter critical care database from the Philips eICU Research Institute was used for external validation. A total of 103 clinical features were extracted from the first day after admission. We developed an AI model using gradient-boosting machines to predict the mortality risk of sepsis and used Mondrian conformal prediction to estimate the prediction uncertainty. The Shapley additive explanation method was used to explain the model. RESULTS A total of 16,746 (80%) patients from Beth Israel Deaconess Medical Center were used to train the model. When tested on the internal validation population of 4187 (20%) patients, the model achieved an area under the receiver operating characteristic curve of 0.858 (95% CI 0.845-0.871), which was reduced to 0.800 (95% CI 0.789-0.811) when externally validated on 10,362 patients from the Philips eICU database. At a specified confidence level of 90% for the internal validation cohort the percentage of error predictions (n=438) out of all predictions (n=4187) was 10.5%, with 1229 (29.4%) predictions requiring clinician review. In contrast, the AI model without conformal prediction made 1449 (34.6%) errors. When externally validated, more predictions (n=4004, 38.6%) were flagged for clinician review due to interdatabase heterogeneity. Nevertheless, the model still produced significantly lower error rates compared to the point predictions by AI (n=1221, 11.8% vs n=4540, 43.8%). The most important predictors identified in this predictive model were Acute Physiology Score III, age, urine output, vasopressors, and pulmonary infection. Clinically relevant risk factors contributing to a single patient were also examined to show how the risk arose. CONCLUSIONS By combining model explanation and conformal prediction, AI-based systems can be better translated into medical practice for clinical decision-making.

  • Open Access

    Entropy Analysis of Heart Rate Variability in Different Sleep Stages

    by Chang Yan, Peng Li, Meicheng Yang, Yang Li, Jianqing Li, Hongxing Zhang, Chengyu Liu

    How the complexity or irregularity of heart rate variability (HRV) changes across different sleep stages and the importance of these features in sleep staging are not fully understood. This study aimed to investigate the complexity or irregularity of the RR interval time series in different sleep stages and explore their values in sleep staging. We performed approximate entropy (ApEn), sample entropy (SampEn), fuzzy entropy (FuzzyEn), distribution entropy (DistEn), conditional entropy (CE), and permutation entropy (PermEn) analyses on RR interval time series extracted from epochs that were constructed based on two methods: (1) 270-s epoch length and (2) 300-s epoch length. To test whether adding the entropy measures can improve the accuracy of sleep staging using linear HRV indices, XGBoost was used to examine the abilities to differentiate among: (i) 5 classes [Wake (W), non-rapid-eye-movement (NREM), which can be divide into 3 sub-stages: stage N1, stage N2, and stage N3, and rapid-eye-movement (REM)]; (ii) 4 classes [W, light sleep (combined N1 and N2), deep sleep (N3), and REM]; and (iii) 3 classes: (W, NREM, and REM). SampEn, FuzzyEn, and CE significantly increased from W to N3 and decreased in REM. DistEn increased from W to N1, decreased in N2, and further decreased in N3; it increased in REM. The average accuracy of the three tasks using linear and entropy features were 42.1%, 59.1%, and 60.8%, respectively, based on 270-s epoch length; all were significantly lower than the performance based on 300-s epoch length (i.e., 54.3%, 63.1%, and 67.5%, respectively). Adding entropy measures to the XGBoost model of linear parameters did not significantly improve the classification performance. However, entropy measures, especially PermEn, DistEn, and FuzzyEn, demonstrated greater importance than most of the linear parameters in the XGBoost model.300-s270-s.